CTOs on the Move

Nkarta Therapeutics

www.nkartatx.com

 
Nkarta is a clinical-stage biotechnology company advancing the development of allogeneic natural killer (NK) cell therapies for cancer. By combining its cell expansion and cryopreservation platform with proprietary cell engineering technologies, Nkarta is building a pipeline of cell therapy candidates generated by efficient manufacturing processes, and engineered to enhance tumor targeting and improve persistence for sustained activity in the body.
  • Number of Employees: 100-250
  • Annual Revenue: $10-50 Million
  • www.nkartatx.com
  • 6000 Shoreline Court Suite 102
    South San Francisco, CA USA 94080
  • Phone: 650.215.0385

Executives

Name Title Contact Details
Ralph Brandenberger
 Senior Vice President of Technical Operations Profile
Ralph Brandenberger
 Chief Technical Officer Profile

Funding

Nkarta Therapeutics raised $114M on 09/04/2019

Similar Companies

Veterans Evaluation Services

Veterans Evaluation Services is a company that supports the U.S. Department of Veterans Affairs in providing veterans and transitioning service members with the benefits theyve earned through their service to the country. They provide high quality, ti...

Magellan Medicaid Administration

Magellan Medicaid Administration is a Glen Allen, VA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

B C Decker

B C Decker Inc. is a Hamilton, ON-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Health Communication Systems

Health Communication Systems is a New York, NY-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Northwestern University Clinical andTranslational Sciences Institute (NUCATS)

NUCATS provides scientists with consultative resources and expertise in order to accelerate how quickly transformative scientific discoveries make their way to patients and the community. It is our goal to continually increase the quality, safety, efficiency and speed of innovative clinical and translational research.